“Operative Closure Technique Utilizing Bovine Collagen Fragments in a Prospective Analysis of 102 Consecutive Neurosurgery Patients” by Rob Dickerman, Ashley S. Reynolds NP, and Karl Winters, published in JSM Neurosurgery and Spine.
We are pleased to announce the publication of the paper “Operative Closure Technique Utilizing Bovine Collagen Fragments in a Prospective Analysis of 102 Consecutive Neurosurgery Patients” by Rob Dickerman, Ashley S. Reynolds NP, and Karl Winters, in JSM Neurosurgery and Spine. Dr. Dickerman is Clinical Associate Professor of Neurosurgery, Department of Neurosurgery, University of North Texas Health Science Center, and Director of Neurosurgery at Presbyterian Hospital of Plano, Texas. The authors present a prospective study of 102 consecutive cranial or spinal neurosurgery cases in which 1 gram of Vancomycin powder was mixed with 1 gram of Activated Collagen® (CellerateRX® Surgical Hydrolyzed Collagen powder) and then placed within the surgical incision. In the 102 consecutive cases, they did not have a single event of wound dehisce or infection during the 16-week follow up. They hypothesize that the aqueous vancomycin bound to the hydrolyzed collagen, prolonging the antimicrobial environment in the surgical site. The full article can be found at:
Please note that some of the product uses described in this publication have not been approved or cleared by FDA. Please review the prescribing information and indications for use of these products.
Payment was made by Wound Care Innovations to Dr. Dickerman’s staff to cover expenses related to photography and data collection. Wound Care Innovations, LLC is a wholly-owned subsidiary of Wound Management Technologies, Inc.
DESIGNED BY NATURE ♦ ACTIVATED BY SCIENCE
Copyright © 2018 All Rights Reserved, Wound Care Innovations, LLC – A WNDM Medical, Inc. company.
CellerateRX® is a trademark of Applied Nutritionals, LLC. Activated Collagen® and CRXα® are trademarks of WNDM Medical, Inc.